The U.S. Depart of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded a $749K contract to Genmark Diagnostics (GNMK -18.2%)
to develop a second-generation (v2) Dx ePlex Respiratory Pathogen Panel
that (presumably) includes SARS-CoV-2 (the current version includes
coronaviruses 229E, HKU1, NL63 and OC43).
https://seekingalpha.com/news/3554355-genmark-diagnostics-nabs-barda-contract-to-develop-respiratory-pathogen-panel
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.